Clinical Research Directory

Inclusion Criteria: * Children 6-52.9 months at Baseline. This is so that children are 6-59 months by end of study (6-7 months from baseline) * Children with MAM (WHZ/WLZ \<-2 and ≥-3 and/or MUAC \<125mm and ≥115mm) * No Medical Complications (passes IMCI screening questions) * No oedema * Child does not deteriorate to SAM (WHZ/WLZ\<-3 and/or MUAC\<115mm) because child should be referred to health centre * Caregiver refuses to receive age-appropriate immunization, Vitamin A and deworming minimum 2 weeks before PDH begins * Child is not planning to live outside the study area routinely for more than 2 weeks during the 3 months of the study * Written/Oral consent is given by Parent/Caregiver to participate in the study Exclusion Criteria: * Child is not between 6-52 months of age at Baseline * Child does not meet the inclusion criteria for WHZ/WLZ and/or MUAC; (WHZ/WLZ \<-2SD and ≥-3SD and/or MUAC \<125mm and ≥115mm); * Child has oedema; * Child has medical complications and/or does not pass the IMCI screening including fever, nausea/vomiting, acute respiratory illness (refer to Study Protocol V2.0, 19 Feb 2026); * Deteriorates to SAM and must be removed from the study and referred to the health centre for specially formulated food (SFF) treatment; * Refuses to receive minimum 2 weeks before the intervention begins, age-appropriate immunization and Vitamin A and deworming in the past 6 months; * Child lives outside the study area routinely or will be outside of the study area for more than 2 weeks in the upcoming 3 months * Parent/Caregiver unable or unwilling to attend PDH from start; * Parent/Caregiver does not provide written or oral consent to screen for the trial; * Parent/Caregiver does not provide informed consent for the study; and * any other reason.